In the News

“Genetic Scissors: at the cutting-edge of life” (WIPO Magazine)

“Four key takeaways from the latest CRISPR patent wars decision” (IAM)

“MPEG LA builds new biotech licensing programmes and remains hopeful on CRISPR pool” (IAM)

“Analysis: Broad Institute Loses Appeal on European CRISPR Patent” (Labiotech)

“Sigma-Aldrich Petitions for Interference Between 3 Applications, UC Patents for CRISPR Methods in Eukaryotic Cells” (GEN)

“CRISPR patent pool will do little to quash licensing uncertainties” (IAM)

“MPEG LA Issues Statement Regarding CRISPR Patent Licensing” (MPEG LA)

“Get ready for the first CRISPR Patent Pool” (IAM)

“CRISPR-Cas9 Germline Editing: Full Steam Ahead to Revolutionary Profit or Revolutionary Public Medicine?” (UOJM)

“Clearing a way through the CRISPR patent jungle” (LSIPR)

“As CRISPR patent fight nears the endgame, where are settlement talks?” (STAT)

“This Court Battle Will Decide Who Will Make a Fortune From Gene-Editing Tech” (Bloomberg News)

“The competition law issues of the CRISPR patent pool” (Lexology)

“Keynote Presentation by Kristin Neuman at the LES France General Assembly” (5 December 2017)

“Broad had ‘no clue’ about CRISPR licensing in agriculture” (LSIPR)

“Amazing gene-editing technology needs a pass on patent minefields” (The Mercury News)

“Making a splash in the CRISPR patent pool” (LSIPR)

“Flux and Uncertainty in the CRISPR Patent Landscape” (The Scientist)

“CRISPR patent estate splinters” (Nature Biotechnology)

“Patent Pool Seeks to Ease Gene-Editing Tech Licensing” (Patent, Trademark & Copyright Journal)

“First CRISPR patent pool signs up key patent owner, but significant challenges remain” (IAM)

“Broad Institute backs central Crispr patent licensing platform” (The Royalty Society of Chemistry)

“‘Jury’s Still Out’ On CRISPR Patent Licensing Pool” (Law360)

“Loving Prime Day, Fighting a Duopoly, and Getting Hip to CRISPR” (The Motley Fool)

“Broad Institute enters talks for CRISPR licensing pool” (LSIPR)

“CRISPR Patent Holders Agree to Patent Pool” (Front Line Genomics)

“Broad Throws Down the Gauntlet for CRISPR Pool” (Bio Century)

“Major CRISPR Patent-Holders Agree to Patent Pool” (TheScientist)

“Broad Institute Joins CRISPR Patent Pool Talks” (Genetic Engineering & Biotechnology News)

“Broad institute of MIT and Harvard joins discussions to create worldwide CRISPR-Cas9 licensing pool” (Broad Institute)

“The Broad Institute of MIT and Harvard Among Those Participating in MPEG LA’s CRISPR-Cas9 Joint Licensing Facilitation”

“Crispr Patent-Holders Move Toward Easing Access to Gene-Editing Technology” (The Wall Street Journal)

“Patent pools in the life sciences: a potential facilitator of CRISPR commercialization” (IAM Life Sciences 2017)
This article first appeared in IAM Life Sciences 2017, a supplement to IAM, published by Globe Business Media Group – IP Division. To view the guide in full, please go to

“Biotech Patent Pools: CRISPR-Cas9” (Updated from a presentation made at BIO International 2017)

“Kristin Neuman to Speak About MPEG LA’s CRISPR Pool License at NewYorkBIO and AIPLA”

“MPEG LA Invites CRISPR-Cas9 Patents to be Pooled in a One-Stop License”

“Disputes Continue over Foundational Patents for Gene Editing” (Genomics Law Report)

“Patent pools for CRISPR technology” (Letter to the Editor, Science)

“U of California Vows CRISPR Patent Spat Not Over as Experts Weigh in on Legal Options” (GenomeWeb)

“CRISPR Patent Licensing: An Opportunity to Leverage Experience from Patent Pool Models to Help this Technology Reach its Full Potential” (Biotech Buzz, American Intellectual Property Law Association)

” ‘One-Stop’ CRISPR licensing initiative looks to accelerate the technology’s benefits”

“MPEG LA to Pursue All-In-One CRISPR License Solution” (GenomeWeb)

“MPEG LA Initiative to Address CRISPR Licensing”